LGALS3 and stroke disorder: In the high galectin-3 group, the composite of all-cause mortality, non-fatal MI, and stroke occurred in a total of 65 patients (13.8%), while in the low galectin-3 group, they occurred only in 27 patients (5.8%) during long-term follow-up.